Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05846399Phase 4Recruiting
Phase 4, randomised, double-blind trial of amoxicillin + clavulanate in bacterial infection (3 arms), sponsored by University of Missouri. Primary endpoint: Incidence of infection at 30 days. Started Sep 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05846399.